Table 1 Subjects' characteristics and linear correlation analyses between circulating baseline omentin-1 concentrations and baseline parameters in all subjects.
From: Circulating omentin concentration increases after weight loss
All subjects (n = 35) | |||||
|---|---|---|---|---|---|
Baseline | After weight loss | p | r* | p* | |
Age (years) | 42.4 ± 15.2 | 0.23 | 0.2 | ||
Body Mass Index (kg/m 2 ) | 33.3 ± 4.2 | 28.9 ± 4.4 | <0.001 | -0.58 | <0.001 |
Body weight (kg) | 95.4 ± 17.5 | 82.4 ± 14.7 | <0.001 | -0.35 | 0.045 |
Fat mass (%) | 41.8 ± 8.2 | 33.9 ± 9.9 | <0.001 | -0.67 | <0.001 |
Waist (cm) | 106.4 ± 11.4 | 96.4 ± 11.7 | <0.001 | -0.15 | 0.4 |
Hip (cm) | 112.8 ± 10.3 | 104.4 ± 9.4 | <0.001 | -0.58 | <0.001 |
Waist to hip ratio | 0.95 ± 0.08 | 0.92 ± 0.07 | <0.001 | 0.28 | 0.1 |
Fasting glucose (mmol/l) | 5.2 ± 0.5 | 5 ± 0.43 | 0.04 | 0.23 | 0.2 |
Fasting triglycerides (mmol/l) | 1.23 ± 0.5 | 0.92 ± 0.36 | 0.001 | 0.17 | 0.3 |
HDL-cholesterol (mmol/l) | 1.37 ± 0.3 | 1.28 ± 0.28 | 0.05 | -0.08 | 0.7 |
LDL-cholesterol (mmol/l) | 3.3 ± 0.8 | 2.7 ± 0.59 | <0.001 | 0.28 | 0.1 |
Total cholesterol (mmol/l) | 5.2 ± 0.9 | 4.45 ± 0.61 | <0.001 | 0.3 | 0.08 |
Fasting insulin (mU/l) | 16.1 ± 8.6 | 12.06 ± 6.4 | 0.005 | -0.37 | 0.03 |
HOMA value | 3.6 ± 2.04 | 2.6 ± 1.4 | 0.009 | -0.3 | 0.08 |
Circulating leptin (ng/ml) | 35.7 ± 22.2 | 13.2 ± 18.2 | <0.001 | -0.7 | <0.001 |
Circulating omentin-1 (ng/ml) | 44.9 ± 9.02 | 53.4 ± 8.8 | <0.001 | ||